Gift Opening
$200 Off MarketBeat All Access
Thanks for being one of our best subscribers! You are eligible for a limited-time discount.
  •  days
  •  Hours
  •  Minutes
  •  Seconds
Claim Your Discount
×
Free Trial
Thank you for registering! Take a moment to confirm your subscription to MarketBeat Daily Ratings so that you can access MarketBeat's tools, reports, and news. Please click the "Send Confirmation Email" button and we'll send you an email with confirmation instructions.
Send Confirmation Email
→ Bill Gates’s Next Big AI Bet: Stargate (From Brownstone Research) (Ad) Free VKTX Stock Alerts

Viking Therapeutics (VKTX) Earnings Date, Estimates & Call Transcripts

Viking Therapeutics logo
$55.06 -5.54 (-9.14%)
(As of 11/13/2024 ET)
Compare

Viking Therapeutics Latest Earnings Summary

Upcoming Q4
Earnings Date
Feb. 5Estimated
Actual EPS
(Oct. 23)
-$0.22 Beat By $0.02
Consensus EPS
(Oct. 23)
-$0.24

Viking Therapeutics issued Q3 2024 earnings on October 23, 2024, reporting an EPS of -$0.22, which beat the consensus estimate of -$0.24 by $0.02. With a trailing EPS of -$0.93, Viking Therapeutics' earnings are expected to decrease next year, from ($0.98) to ($1.44) per share.

VKTX Upcoming Earnings

Viking Therapeutics' next earnings date is estimated for Wednesday, February 5, 2025, based off prior year's reporting schedules.

Skip Charts & View Estimated and Actual Earnings Data

VKTX Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

VKTX Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Viking Therapeutics Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20243-$0.27-$0.25-$0.26
Q2 20243-$0.28-$0.17-$0.24
Q3 20243-$0.29-$0.23-$0.26
Q4 20243-$0.27-$0.24-$0.25
FY 202412-$1.11-$0.89-$1.02
Q1 20251-$0.28-$0.28-$0.28
Q2 20251-$0.28-$0.28-$0.28
Q3 20251-$0.30-$0.30-$0.30
Q4 20251-$0.29-$0.29-$0.29
FY 20254($1.15)($1.15)($1.15)

Viking Therapeutics Earnings History by Quarter

Export to Excel
DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks
2/5/2025
(Estimated)		------- 
10/23/2024Q3 2024-$0.24-$0.22+$0.02-$0.22--    
7/24/2024Q2 2024-$0.26-$0.20+$0.06-$0.20--      
4/24/2024Q1 2024-$0.27-$0.26+$0.01-$0.26--      
2/7/2024Q4 2023-$0.25-$0.25--$0.25--      
10/25/2023Q3 2023-$0.22-$0.23 -$0.01-$0.23--      
7/26/2023Q2 2023-$0.21-$0.19+$0.02-$0.19--      
Financial Prophecy (Ad)

The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold $3 billion of Amazon… it’s why Nvidia’s CEO just sold $713 million... and it’s why Zuckerberg just sold $1.3 billion in Meta stock. The financial establishment doesn’t want you to know about this… but a controversial new documentary just pulled back the curtain and exposed what’s really going on. It’s called The Final Frontier.

Including the name of the #1 company to buy.
4/26/2023Q1 2023-$0.24-$0.25 -$0.01-$0.25--  
2/8/2023Q4 2022-$0.23-$0.26 -$0.03-$0.26--  

Viking Therapeutics Earnings - Frequently Asked Questions

Viking Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, February 5th, 2025 based off last year's report dates. Learn more on VKTX's earnings history.

In the previous quarter, Viking Therapeutics (NASDAQ:VKTX) reported ($0.22) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.24) by $0.02. Learn more on analysts' earnings estimate vs. VKTX's actual earnings.

The conference call for Viking Therapeutics's latest earnings report can be listened to online.
Listen to Conference Call

The conference call transcript for Viking Therapeutics's latest earnings report can be read online.
Read Transcript

Viking Therapeutics (NASDAQ:VKTX) has a recorded net income of -$85.89 million. VKTX has generated -$0.93 earnings per share over the last four quarters.

Viking Therapeutics's earnings are expected to decrease from ($0.98) per share to ($1.44) per share in the next year.

`

More Earnings Resources from MarketBeat

Related Companies
Earnings Tools
Earnings By Country
Latest Articles


This page (NASDAQ:VKTX) was last updated on 11/13/2024 by MarketBeat.com Staff
From Our Partners
Bill Gates’s Next Big AI Bet: Stargate
In February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...
Brownstone Research | Sponsored
Tim Sykes’ Urgent Trade Alert: “Make this move now”
WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...
Timothy Sykes | Sponsored
Trump’s IRS Hands Massive ‘Victory Gift’ To 401K Owners
The "Fake Media" has completely ignored Trump's genius "victory gift" to all America First patriots like you. ...
Colonial Metals | Sponsored
Unveiled: NVIDIA’s "Secret Royalty" Program
Did you know that there's an investment that will give you the opportunity to collect "royalties" every time N...
Behind the Markets | Sponsored
You just voted for a financial crisis
I’d like to share with you my #1 high-conviction stock to buy before Inauguration Day… and details on the asse...
Porter & Company | Sponsored
Musk Says ‘Dollar Will Be Worth Nothing…’
Elon Musk just issued an urgent warning… It's no secret that Musk is able to move markets with his words…
Crypto 101 Media | Sponsored
24/7 Automated Profits in Crypto
What if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...
Crypto Swap Profits | Sponsored
Musk’s new company could top a trillion?
The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...
Paradigm Press | Sponsored